Central retinal vein occlusion post-COVID-19 vaccination
Reads0
Chats0
TLDR
In this paper , the authors present two cases of central retinal vein occlusion presenting immediately after receiving the second dose of the Covishield vaccine, although the causal relationship cannot be drawn, the ophthalmologist should be aware of this adverse reaction.Abstract:
Coronavirus disease 2019 (COVID-19) is known to cause thromboembolic episodes apart from acute respiratory distress syndrome (ARDS). With large vaccine drives all across the world, there are a few case reports on post-vaccine thrombotic events seen with the AZD1222, ChAdO × 1 vaccine. Here, we present two cases of central retinal vein occlusion presenting immediately after receiving the second dose of the Covishield vaccine. Although the causal relationship cannot be drawn, the ophthalmologist should be aware of this adverse reaction. read more
Citations
More filters
Journal ArticleDOI
Branch retinal vein occlusion in a healthy young man following mRNA COVID-19 vaccination
TL;DR: In this article , the authors reported a case of branch retinal vein occlusion (BRVO) following mRNA COVID-19 vaccination with BNT162b2 (Pfizer-BioNTech) mRNA vaccine.
Journal ArticleDOI
COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion
TL;DR: Adenoviral vector vaccine promotes both cellular and humoral immune responses, increasing the level of inflammatory cytokines, the same implied in the possible pathogenesis of central retinal vein occlusion.
Journal ArticleDOI
Retinal vascular occlusion and SARS-CoV-2 vaccination
TL;DR: In this article , a case series of all consecutive adult patients with new onset VO within 6 weeks of vaccination against COVID-19 were included in the study between May 1 and October 31, 2021, and the median time between vaccination and symptoms onset was 14 days (range 7-42 days).
Journal ArticleDOI
Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature
TL;DR: A 28-year-old healthy male presented with blurring of vision in the right eye following third dose of the AstraZeneca/COVISHIELD vaccine and subsequent laboratory investigations were inconclusive for his eye disease as mentioned in this paper .
Journal ArticleDOI
Ischemic retinal events after COVID-19 vaccination
TL;DR: In this paper , the authors reported two cases of ischemic retinal events occurring soon after administration of the Moderna and Johnson & Johnson/Janssen COVID-19 vaccines.
References
More filters
Journal ArticleDOI
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
P M Folegatti,Katie J. Ewer,Parvinder K. Aley,Brian Angus,Stephan Becker,Sandra Belij-Rammerstorfer,D Bellamy,S Bibi,M Bittaye,Elizabeth A. Clutterbuck,Christina Dold,Saul N. Faust,Adam Finn,Amy Flaxman,Bassam Hallis,Paul T. Heath,D Jenkin,Rajeka Lazarus,R Makinson,Angela M. Minassian,Katrina M Pollock,M N Ramasamy,Hannah Robinson,Matthew D. Snape,R Tarrant,Merryn Voysey,Catherine M. Green,Alexander D. Douglas,Hill Avs.,Teresa Lambe,Sarah C. Gilbert,Andrew J. Pollard +31 more
TL;DR: A phase 1/2, single-blind, randomized controlled trial in five trial sites in the UK of a chimpanzee adenovirus-vectored vaccine (ChAdOx1 nCoV-19) expressing the SARS-CoV2 spike protein compared with a meningococcal conjugate vaccine (MenACWY) as control was conducted.
Journal ArticleDOI
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Andreas Greinacher,Thomas Thiele,Theodore E. Warkentin,Karin Weisser,Paul A. Kyrle,Sabine Eichinger +5 more
TL;DR: In this article, the authors reported several cases of unusual thrombotic events and thrombo-cellocytopenia after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of spike proteins.
Journal ArticleDOI
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
Anton Pottegård,Lars Christian Lund,Øystein Karlstad,Jesper Dahl,Morten Andersen,Jesper Hallas,Øjvind Lidegaard,German Tapia,Hanne Løvdal Gulseth,Paz Lopez-Doriga Ruiz,Sara Sofie Viksmoen Watle,Anders P. Mikkelsen,Lars Pedersen,Lars Pedersen,Henrik Toft Sørensen,Henrik Toft Sørensen,Reimar W. Thomsen,Reimar W. Thomsen,Anders Hviid,Anders Hviid +19 more
TL;DR: In this paper, the authors assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and compare them with rates observed in the general populations.
Journal ArticleDOI
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Colin R Simpson,Colin R Simpson,Ting Shi,Eleftheria Vasileiou,Srinivasa Vittal Katikireddi,Shona M. Kerr,Emily Moore,Colin McCowan,Utkarsh Agrawal,Syed Ahmar Shah,Lewis D Ritchie,Josie Murray,Jiafeng Pan,Declan Bradley,Sarah J. Stock,Rachael Wood,Antony Chuter,Jillian Beggs,Helen R. Stagg,Mark Joy,Ruby S. M. Tsang,S de Lusignan,Richard J. Hobbs,Ronan A Lyons,Fatemeh Torabi,Stuart Bedston,M O'Leary,Ashley Akbari,Jim McMenamin,Chris Robertson,Aziz Sheikh +30 more
TL;DR: In this article, an association was found between exposure to first-dose ChAdOx1 or BNT162b2 vaccination and hematological and vascular adverse events using a nested incident-matched case-control study and a confirmatory self-controlled case series (SCCS) analysis.
Journal ArticleDOI
Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
TL;DR: In this paper, the authors report a case from Panama with SARS-CoV-2 infection complicated by acute transverse myelitis (ATM) and present a comprehensive clinical review of 43 patients with COVID-19-associated ATM from 21 countries published from March 2020 to January 2021.
Related Papers (5)
COVID-19 ARDS: clinical features and differences to “usual” pre-COVID ARDS
The SARS‐CoV‐2 omicron wave is indicating the end of the pandemic phase but the COVID‐19 will continue
Sohel Daria,Rabiul Islam +1 more